Tag: hormoneReplacementTherapy
Hormone replacement therapy (HRT): Drug therapy designed to replace female hormones whose levels drop as a result of menopause. Most U.S. women are prescribed combination or combined HRT, which consists of estrogen plus progestin, rather than estrogen-only HRT.
Articles
News
Foods
Studies
- A case-control study on hormone therapy as a risk factor for breast cancer in Finland: Intrauterine system carries a risk as well
- A cluster of inflammatory breast cancer (IBC) in an office setting: additional evidence of the importance of environmental factors in IBC etiology
- Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study
- Age and Menopausal Effects of Hormonal Birth Control and Hormone Replacement Therapy in Relation to Breast Cancer Risk
- Alcohol consumption and breast cancer risk among postmenopausal women following the cessation of hormone therapy use: the California Teachers Study
- Apigenin Induces Apoptosis and Blocks Growth of Medroxyprogesterone Acetate-Dependent BT-474 Xenograft Tumors
- Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats
- Association of Hormone-Related Characteristics and Breast Cancer Risk by Estrogen Receptor/Progesterone Receptor Status in the Shanghai Breast Cancer Study
- Body mass index (BMI), change in BMI, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
- Body size and the risk of postmenopausal breast cancer subtypes in the California Teachers Study cohort
- Breast Cancer Incidence and Hormone Replacement Therapy in Canada
- Breast cancer patients with lobular cancer more commonly have a father than a mother diagnosed with cancer
- Breast Cancer Risk by Breast Density, Menopause, and Postmenopausal Hormone Therapy Use
- Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women’s health initiative clinical trials
- Change in mammographic density with estrogen and progestin therapy: A measure of breast cancer risk in the Women’s Health Initiative
- Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial
- Curcumin delays development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors
- Dietary β-carotene, vitamin C and E intake and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition
- Dietary carbohydrates and breast cancer risk: A prospective study of the roles of overall glycemic index and glycemic load
- Dual Estrogen Effects on Breast Cancer: Endogenous Estrogen Stimulates, Exogenous Estrogen Protects. Further Investigation of Estrogen Chemoprevention Is Warranted
- Effect of oral phytoestrogen on androgenicity and insulin sensitivity in postmenopausal women
- Effects of Omega-3 Fatty Acids on Progestin Stimulation of Invasive Properties in Breast Cancer
- Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women
- Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women’s Health Initiative Observational Study
- Estrogen-Progestagen Menopausal Hormone Therapy and Breast Cancer: Does Delay From Menopause Onset to Treatment Initiation Influence Risks?
- Hops (Humulus lupulus) Inhibits Oxidative Estrogen Metabolism and Estrogen-Induced Malignant Transformation in Human Mammary Epithelial cells (MCF-10A)
- Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial
- Hormone Therapy Use and Breast Cancer Incidence by Histological Subtypes in Sweden and Norway
- Hormone Therapy, Estrogen Metabolism, and Risk of Breast Cancer in the Women's Health Initiative Hormone Therapy Trial
- Hormone Treatment, Estrogen Receptor Polymorphisms and Mortality: A Prospective Cohort Study
- Hot flashes, hormone therapy, and breast cancer risk: The Women’s Health Initiative Clinical Trials
- Intake of whole grain products and risk of breast cancer by hormone receptor status and histology among postmenopausal women
- Interactions between intakes of alcohol and postmenopausal hormones on risk of breast cancer
- Long-term use of hormone therapy and breast cancer incidence and mortality
- Mammographic breast density and breast cancer risk by menopausal status, postmenopausal hormone use and a family history of breast cancer
- Mammographic Density, Response to Hormones, and Breast Cancer Risk
- Meat Intake and Mortality
- Menopausal hormone therapy and breast cancer risk: Impact of different treatments. The European prospective investigation into cancer and nutrition (EPIC)
- Modifiable risk factors and survival in women diagnosed with primary breast cancer: results from a prospective cohort study
- Multicenter, Randomized, Cross-Over Clinical Trial of Venlafaxine Versus Gabapentin for the Management of Hot Flashes in Breast Cancer Survivors
- Nandrolone and stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation
- New-Onset Breast Tenderness After Initiation of Estrogen Plus Progestin Therapy and Breast Cancer Risk
- No Difference Between Red Wine or White Wine Consumption and Breast Cancer Risk
- Physical activity, sitting time, and postmenopausal breast cancer risk by histopathologic characteristics in a large US cohort
- Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors
- Progesterone-Inducible Cytokeratin 5-Positive Cells in Luminal Breast Cancer Exhibit Progenitor Properties
- Progestin drives breast cancer growth by inducing p21CIP1 expression through the assembly of a transcriptional complex among Stat3, progesterone receptor and ErbB-2
- Prospective study of the association between grapefruit intake and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
- Relationship between Menopausal Symptoms and Risk of Postmenopausal Breast Cancer
- Risk Factors for Ductal, Lobular, and Mixed Ductal-Lobular Breast Cancer in a Screening Population
- Risk factors for postmenopausal breast cancer defined by estrogen and progesterone receptor status: The multiethnic cohort
- Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial
- Screening Mammography Use among Current, Former, and Never Hormone Therapy Users May Not Explain Recent Declines in Breast Cancer Incidence
- Soy Isoflavones in the Prevention of Menopausal Bone Loss and Menopausal Symptoms
- Statins and breast cancer in postmenopausal women without hormone therapy
- The Changing Incidence of In situ and Invasive Ductal and Lobular Breast Carcinomas: United States, 1999-2004
- The Use of Herbal Preparations to Alleviate Climacteric Disorders and Risk of Postmenopausal Breast Cancer in a German Case-Control Study
- ZEN and the art of breast health maintenance